Alignment Healthcare (ALHC)
(Delayed Data from NSDQ)
$7.26 USD
+0.27 (3.86%)
Updated May 17, 2024 04:00 PM ET
After-Market: $7.25 -0.01 (-0.14%) 7:20 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Alignment Healthcare (ALHC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.23 | $11.00 | $4.50 | 17.74% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Alignment Healthcare comes to $8.23. The forecasts range from a low of $4.50 to a high of $11.00. The average price target represents an increase of 17.74% from the last closing price of $6.99.
Analyst Price Targets (11)
Broker Rating
Alignment Healthcare currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 2.17 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, seven are Strong Buy, representing 58.33% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 6 | 6 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 5 | 5 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 0 |
ABR | 2.00 | 2.00 | 2.17 | 2.17 | 1.73 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/8/2024 | Piper Sandler | Jessica E Tassan | Hold | Strong Buy |
5/5/2024 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
5/3/2024 | Stephens | Scott Fidel | Hold | Hold |
3/6/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
1/9/2024 | Raymond James | John W Ransom | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 12 |
Average Target Price | $8.23 |
LT Growth Rate | 42.80% |
Industry | Medical Services |
Industry Rank by ABR | 92 of 252 |
Current Quarter EPS Est: | -0.14 |